Cartesian Therapeutics, Inc. financial data

Symbol
RNAC, SELB on Nasdaq
Industry
Pharmaceutical Preparations
Location
65 Grove Street, Watertown, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
SELECTA BIOSCIENCES INC (to 11/13/2023)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 269 % -52.6%
Debt-to-equity -233 % -332%
Return On Equity 236 %
Return On Assets -116 % -1229%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 162M shares +5.55%
Common Stock, Shares, Outstanding 5.52M shares -96.4%
Entity Public Float 129M USD -14%
Common Stock, Value, Issued 1K USD -93.3%
Weighted Average Number of Shares Outstanding, Basic 5.41M shares +5.92%
Weighted Average Number of Shares Outstanding, Diluted 5.41M shares +5.92%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 25.9M USD -68.7%
Research and Development Expense 63M USD -14.1%
General and Administrative Expense 44.3M USD +84.6%
Operating Income (Loss) -81.4M USD -457%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -239M USD -787%
Income Tax Expense (Benefit) -19M USD -3020%
Net Income (Loss) Attributable to Parent -255M USD -1592%
Earnings Per Share, Basic -7.92 USD/shares -87.2%
Earnings Per Share, Diluted -7.92 USD/shares -87.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 103M USD -17.9%
Accounts Receivable, after Allowance for Credit Loss, Current 2.01M USD -70.7%
Assets, Current 111M USD -19.7%
Property, Plant and Equipment, Net 2.4M USD -13.1%
Operating Lease, Right-of-Use Asset 9.56M USD -14.7%
Goodwill 48.2M USD
Assets 325M USD +109%
Accounts Payable, Current 2.52M USD +137%
Employee-related Liabilities, Current 1.7M USD -22.9%
Accrued Liabilities, Current 8.93M USD -4.49%
Contract with Customer, Liability, Current 412K USD -90.3%
Liabilities, Current 36.7M USD +38.2%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 15.9M USD
Operating Lease, Liability, Noncurrent 8.23M USD -14.4%
Liabilities 442M USD +445%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.61M USD -0.79%
Retained Earnings (Accumulated Deficit) -671M USD -61.2%
Stockholders' Equity Attributable to Parent -117M USD -257%
Liabilities and Equity 325M USD +109%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.9M USD -81.6%
Net Cash Provided by (Used in) Financing Activities 43M USD +28780%
Net Cash Provided by (Used in) Investing Activities -602K USD -102%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 5.52M shares -96.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 26.5M USD +36%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 105M USD -17.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 124M USD -2.76%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 152M USD +16.3%
Operating Lease, Liability 10.5M USD -7.36%
Depreciation 700K USD -12.5%
Payments to Acquire Property, Plant, and Equipment 602K USD +363%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -255M USD -1596%
Lessee, Operating Lease, Liability, to be Paid 12.7M USD -11.9%
Property, Plant and Equipment, Gross 8.23M USD +0.92%
Operating Lease, Liability, Current 2.23M USD +33.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.25M USD +15.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.16M USD +15.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) -19M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.23M USD -28.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.02M USD +3.96%
Deferred Tax Assets, Operating Loss Carryforwards 29.8M USD +75.4%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) -19M USD -3067%
Preferred Stock, Shares Authorized 9.45M shares -5.48%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 946K USD -68.4%
Operating Lease, Payments 761K USD +16.5%
Additional Paid in Capital 559M USD +12.8%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 24.9M USD +133%
Interest Expense 2.03M USD -35.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%